This became more relevant after Yi Fan's group demonstrated that blocking PAK4 expression in endothelial cells could reprogram the tumor vascular microenvironment, thus, facilitating the infiltration of CAR-T cells and improving the efficacy of immunotherapy in glioblastoma (26). Here, PAK4 is linked to glioblastoma.